Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I1BQ
|
||||
Former ID |
DCL000842
|
||||
Drug Name |
IL-18BP
|
||||
Indication | B-cell non-hodgkin's lymphoma; Rheumatoid arthritis [ICD9: 200, 202, 202.8, 710-719, 714; ICD10:C81-C86, C82-C85, M00-M25, M05-M06] | Discontinued in Phase 1 | [547123] | ||
Company |
Yeda; Merck Serono
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-18 | Target Info | Binder | [536651] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Interleukin signaling pathway | ||||
Toll receptor signaling pathway | |||||
Reactome | Interleukin-1 processing | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.